Prospects for Dietary Therapy of Recurrent Nephrolithiasis

Advances in Chronic Kidney Disease

Volumn 16, Issue 1, 2009, Pages 21-29

  Goldfarb, David S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Calculi; Citrate; Diet; Kidney stones; Oxalate; Renal; Urolithiasis

Indexed keywords

OXALIC ACID; THIAZIDE DIURETIC AGENT;

ARTICLE; CALCIUM INTAKE; CALCIUM STONE; DIET THERAPY; HUMAN; HYPERCALCIURIA; LOW CALORY DIET; LOW FAT DIET; NEPHROLITHIASIS; OBESITY; OXALOBACTER FORMIGENES; PRIORITY JOURNAL; PROTEIN RESTRICTION; RECURRENT DISEASE; RISK REDUCTION; SALT INTAKE; SODIUM RESTRICTION; STONE FORMATION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN; WEIGHT REDUCTION;

HUMANS; NEPHROLITHIASIS; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE;

EID: 57649096250     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2008.10.010     Document Type: Article

References (48)

1. Borghi L., Schianchi T., Meschi T., et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346 (2002) 77-84
2. Dussol B., Iovanna C., Rotily M., et al. A randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis. Nephron Clin Pract 110 (2008) c185-c194
3. Hiatt R.A., Ettinger B., Caan B., et al. Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol 144 (1996) 25-33
4. Borghi L., Meschi T., Amato F., et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: A 5-year randomized prospective study. J Urol 155 (1996) 839-843
5. Taylor E.N., and Curhan G.C. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol 18 (2007) 2198-2204
6. Taylor E.N., and Curhan G.C. Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol 3 (2008) 1453-1460
7. Freel R.W., Hatch M., Green M., et al. Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice. Am J Physiol Gastrointest Liver Physiol 290 (2006) G719-G728
8. Hesse A., Schneeberger W., Engfeld S., et al. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: Application of a new test with [13C2]oxalate. J Am Soc Nephrol 10 suppl 14 (1999) S329-S333
9. Sikora P., von Unruh G.E., Beck B., et al. [13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria. Kidney Int 73 (2008) 1181-1186
10. Massey L.K., Roman-Smith H., and Sutton R.A. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J Am Diet Assoc 93 (1993) 901-906
11. Curhan G.C., Willett W.C., Rimm E.B., et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328 (1993) 833-838
12. Curhan G.C., Willett W.C., Speizer F.E., et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126 (1997) 497-504
13. Goldfarb D.S. Microorganisms and calcium oxalate stone disease. Nephron Physiol 98 (2004) 48-54
14. Hatch M., Cornelius J., Allison M., et al. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int 69 (2006) 691-698
15. Obligado S.H., and Goldfarb D.S. The association of nephrolithiasis with hypertension and obesity: A review. Am J Hypertens 21 (2008) 257-264
16. Taylor E.N., and Curhan G.C. Body size and 24-hour urine composition. Am J Kidney Dis 48 (2006) 905-915
17. Taylor E.N., Stampfer M.J., and Curhan G.C. Obesity, weight gain, and the risk of kidney stones. JAMA 293 (2005) 455-462
18. Maalouf N.M., Cameron M.A., Moe O.W., et al. Low urine pH: A novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2 (2007) 883-888
19. Cameron M.A., Maalouf N.M., Adams-Huet B., et al. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17 (2006) 1422-1428
20. Pak C.Y., Sakhaee K., Moe O., et al. Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61 (2003) 523-527
21. Lieske J.C., de l V., Gettman M.T., et al. Diabetes mellitus and the risk of urinary tract stones: A population-based case-control study. Am J Kidney Dis 48 (2006) 897-904
22. Lemann Jr. J., Pleuss J.A., Worcester E.M., et al. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int 49 (1996) 200-208
23. Norris S.L., Zhang X., Avenell A., et al. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev 2 (2005) CD004095
24. Lieske J.C., Kumar R., and Collazo-Clavell M.L. Nephrolithiasis after bariatric surgery for obesity. Semin Nephrol 28 (2008) 163-173
25. Asplin J.R., and Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 177 (2007) 565-569
26. Shai I., Schwarzfuchs D., Henkin Y., et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359 (2008) 229-241
27. Truby H., Baic S., deLooy A., et al. Randomised controlled trial of four commercial weight loss programmes in the UK: Initial findings from the BBC "diet trials.". BMJ 332 (2006) 1309-1314
28. Dansinger M.L., Gleason J.A., Griffith J.L., et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: A randomized trial. JAMA 293 (2005) 43-53
29. Reddy S.T., Wang C.Y., Sakhaee K., et al. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis 40 (2002) 265-274
30. Kielb S., Koo H.P., Bloom D.A., et al. Nephrolithiasis associated with the ketogenic diet. J Urol 164 (2000) 464-466
31. Sakhaee K., Maalouf N.M., Abrams S.A., et al. Effects of potassium alkali and calcium supplementation on bone turnover in postmenopausal women. J Clin Endocrinol Metab 90 (2005) 3528-3533
32. Ma Y., Pagoto S.L., Griffith J.A., et al. A dietary quality comparison of popular weight-loss plans. J Am Diet Assoc 107 (2007) 1786-1791
33. Appel L.J., Moore T.J., Obarzanek E., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336 (1997) 1117-1124
34. Sacks F.M., Svetkey L.P., Vollmer W.M., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344 (2001) 3-10
35. U.S. Department Of Health And Human Services. Your guide to lowering your blood pressure with DASH. Washington, DC, 2006
36. Ruml L.A., Pearle M.S., and Pak C.Y. Medical therapy, calcium oxalate urolithiasis. Urol Clin North Am 24 (1997) 117-133
37. Weisinger J.R. Bone loss in hypercalciuria: Cause or consequence?. Am J Kidney Dis 33:xlvi-xlviii, (1999)
38. Asplin J.R., Bauer K.A., Kinder J., et al. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int 63 (2003) 662-669
39. Asplin J.R., Donahue S., Kinder J., et al. Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int 70 (2006) 1463-1467
40. Lauderdale D.S., Thisted R.A., Wen M., et al. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 16 (2001) 1893-1898
41. Goldfarb D.S. Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: Are the Recommendations Out of Date?. Rev Urol 4 (2002) 53-60
42. Huen S.C., and Goldfarb D.S. Adverse metabolic side effects of thiazides: Implications for patients with calcium nephrolithiasis. J Urol 177 (2007) 1238-1243
43. Borghi L., Meschi T., Guerra A., et al. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22 suppl 6 (1993) S78-S86
44. Ettinger B., Citron J.T., Livermore B., et al. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139 (1988) 679-684
45. Laerum E., and Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 215 (1984) 383-389
46. Schoofs M.W., van der K.M., Hofman A., et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med 139 (2003) 476-482
47. Appel L.J. The verdict from ALLHAT-thiazide diuretics are the preferred initial therapy for hypertension. JAMA 288 (2002) 3039-3042
48. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002) 2981-2997